Reduced adiponectin levels seem to be not just a mere biomarker of ailment, but play a causal role in the development of IR, MS, T2DM, hypertension, dyslipidemia and atherosclerosis [33,130]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.